tobramycin has been researched along with cefuroxime in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (25.00) | 18.7374 |
| 1990's | 9 (22.50) | 18.2507 |
| 2000's | 15 (37.50) | 29.6817 |
| 2010's | 5 (12.50) | 24.3611 |
| 2020's | 1 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bartlett, M; Crane, JK; Griffin, PS; Miller, MA; Yousuf, M | 1 |
| Faber-Nijholt, R; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
| Robinson, BA; Wilkinson, TJ | 1 |
| Andersen, BM; Bergan, T; Brubakk, O; Bruun, JN; Døskeland, B; Hellum, KB; Hopen, G; Kalager, T; Rahm, V; von der Lippe, E | 1 |
| Bom, VJ; de Vries-Hospers, HG; Dofferhoff, AS; Hazenberg, BP; Mulder, PO; van der Meer, J; van Ingen, J; Weits, J | 1 |
| Pallister, CJ; Warnock, DW | 1 |
| Alestig, K; Bergmark, J; Bergström, T; Hultberg, B; Jagenburg, R; Olaisson, L; Rödjer, S; Trollfors, B; Westin, J | 1 |
| Feshchenko, IuI; Molotkov, VN | 1 |
| Adu, D; Curley, J; Gruer, LD; Michael, J; Turney, JH | 1 |
| Alestig, K; Rödjer, S; Sandberg, T; Trollfors, B; Westin, J | 1 |
| Benini, F; Caramaschi, G; Cetto, GL; Perona, G; Todeschini, G; Vinante, F | 1 |
| Daschner, F | 1 |
| Azzoni, P | 1 |
| Belohradsky, BH; Marget, W; Roos, R | 1 |
| Daenen, SM; de Vries-Hospers, HG; Erjavec, Z; Halie, MR; van der Waaij, D; van Kamp, H | 1 |
| de Araujo, B; Gordon, ES; Holman, J; Webb, LX; Zaccaro, DJ | 1 |
| Hove, H; Mortensen, PB; Tvede, M | 1 |
| Hansen, BA; Heslet, L; Hjortrup, A; Høiby, N; Kirkegaard, P; Moesgaard, F; Rasmussen, A | 1 |
| Amorena, B; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Bring, J; Goscinski, G; Lundholm, M; Odenholt, I; Sjölin, J | 1 |
| Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Goscinski, G; Lundholm, M; Odenholt, I; Sjölin, J | 1 |
| Alvarez, FG; Amorena, B; García-Alvarez, F; García-Alvarez, I; Grasa, JM; Laclériga, A; Monzón, M; Navarro-Zorraquino, M | 1 |
| Goscinski, G; Löwdin, E; Sjölin, J; Tano, E | 1 |
| Murphy, C; Pandita, A | 1 |
| Karenchak, LM; Kowalski, RP; Kowalski, TA; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Castegren, M; Jonsson, AB; Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P | 1 |
| Castegren, M; Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P; Tano, E | 1 |
| Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
5 trial(s) available for tobramycin and cefuroxime
| Article | Year |
|---|---|
Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety.
Topics: Adult; Aged; Bacteremia; Cefuroxime; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Tobramycin; Treatment Outcome; Urinary Tract Infections | 1992 |
Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects.
Topics: Adult; Aged; Ceftazidime; Cefuroxime; Female; Humans; Immunologic Deficiency Syndromes; Kidney; Kidney Function Tests; Male; Middle Aged; Random Allocation; Sepsis; Tobramycin | 1987 |
Renal function in patients treated with tobramycin-cefuroxime or tobramycin-penicillin G.
Topics: beta 2-Microglobulin; Cefuroxime; Cephalosporins; Chromium Radioisotopes; Drug Interactions; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Function Tests; Penicillin G; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Empiric therapy of infections in hematologic malignancies: a prospective, randomized trial.
Topics: Adolescent; Adult; Aged; Ampicillin; Anemia, Aplastic; Carbenicillin; Cefuroxime; Female; Humans; Infections; Leukemia; Lymphoma; Male; Middle Aged; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Aztreonam; Cefuroxime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tobramycin; Treatment Failure; Vancomycin | 1994 |
35 other study(ies) available for tobramycin and cefuroxime
| Article | Year |
|---|---|
In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens; Tobramycin | 1979 |
Selective decontamination of the digestive tract contributes to the control of disseminated intravascular coagulation in severe liver impairment.
Topics: Administration, Oral; Cefuroxime; Colistin; Coxsackievirus Infections; Disseminated Intravascular Coagulation; Enterovirus B, Human; Gram-Negative Bacteria; Hepatitis, Viral, Human; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intestines; Tobramycin | 1992 |
Neutropenic sepsis complicating treatment of solid tumours, lymphoma and myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cefuroxime; Drug Therapy, Combination; Female; Floxacillin; Gentamicins; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasms; Neutropenia; Prospective Studies; Salvage Therapy; Tobramycin | 1992 |
Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans.
Topics: Acute-Phase Proteins; Cefuroxime; Cilastatin; Drug Therapy, Combination; Endotoxins; Female; Humans; Imipenem; Interleukin-1; Interleukin-6; Male; Middle Aged; Sepsis; Tobramycin; Tumor Necrosis Factor-alpha | 1991 |
Effect of antimicrobial and antineoplastic drugs alone and in combination on the phagocytic and candidacidal function of human polymorphonuclear leucocytes.
Topics: Amphotericin B; Anti-Bacterial Agents; Antineoplastic Agents; Candida albicans; Cefuroxime; Ketoconazole; Methotrexate; Neutrophils; Phagocytosis; Prednisolone; Tobramycin; Vinblastine | 1989 |
[Endolymphatic therapy in the combined treatment of patients with respiratory diseases].
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bronchitis; Cefotaxime; Cefuroxime; Evaluation Studies as Topic; Female; Humans; Injections, Intralymphatic; Lung Abscess; Male; Middle Aged; Pneumonia; Respiratory Tract Diseases; Tobramycin | 1985 |
Vancomycin and tobramycin in the treatment of CAPD peritonitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefuroxime; Coagulase; Drug Resistance, Microbial; Exudates and Transudates; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcus; Streptococcus; Tobramycin; Vancomycin | 1985 |
[Klebsiella pneumonia].
Topics: Adult; Cefuroxime; Cephalosporins; Humans; Klebsiella pneumoniae; Male; Pneumonia; Tobramycin | 1980 |
[Cefuroxime-tobramycin treatment of bacterial infections in cancer patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Meningitis, Meningococcal; Neoplasms; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus agalactiae; Tobramycin | 1980 |
Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
Topics: Amikacin; Anti-Bacterial Agents; Cefuroxime; Colistin; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Meningitis; Sepsis; Tobramycin | 1980 |
Antibiotic resistance in staphylococci adherent to cortical bone.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Bone and Bones; Cefuroxime; Drug Resistance, Microbial; Humans; Methylmethacrylates; Nafcillin; Polytetrafluoroethylene; Staphylococcus; Tobramycin; Vancomycin | 1994 |
Antibiotic-associated diarrhoea, Clostridium difficile, and short-chain fatty acids.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clostridioides difficile; Colon; Diarrhea; Fatty Acids, Volatile; Female; Humans; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Nystatin; Tobramycin | 1996 |
Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination.
Topics: Adolescent; Adult; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacterial Infections; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Feces; Graft Rejection; Humans; Infant; Liver Transplantation; Middle Aged; Mycoses; Nystatin; Postoperative Complications; Regression Analysis; Retrospective Studies; Risk Factors; Tobramycin | 1997 |
Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cephalosporins; Male; Microbial Sensitivity Tests; Osteomyelitis; Predictive Value of Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 1998 |
Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release.
Topics: Anti-Bacterial Agents; Cefuroxime; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Interactions; Endotoxins; Escherichia coli; Humans; Microbial Sensitivity Tests; Time Factors; Tobramycin | 2000 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin | 2001 |
Variation in the propensity to release endotoxin after cefuroxime exposure in different gram-negative bacteria: uniform and dose-dependent reduction by the addition of tobramycin.
Topics: Cefuroxime; Dose-Response Relationship, Drug; Drug Interactions; Endotoxins; Escherichia coli; Gram-Negative Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Neisseria; Salmonella; Sensitivity and Specificity; Tobramycin | 2003 |
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tibia; Tobramycin; Vancomycin | 2006 |
Propensity to release endotoxin after two repeated doses of cefuroxime in an in vitro kinetic model: higher release after the second dose.
Topics: Anti-Bacterial Agents; Cefuroxime; Colony Count, Microbial; Culture Media; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Humans; Kinetics; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Tobramycin | 2007 |
Microbial keratitis in Waikato, New Zealand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefuroxime; Child; Child, Preschool; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; New Zealand; Retrospective Studies; Tobramycin | 2011 |
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cefuroxime; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Incidence; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tobramycin | 2013 |
Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Cefuroxime; Critical Care; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunity, Innate; Liver; Male; Sepsis; Spleen; Swine; Tobramycin | 2014 |
Dynamics of Endotoxin, Inflammatory Variables, and Organ Dysfunction After Treatment With Antibiotics in an Escherichia coli Porcine Intensive Care Sepsis Model.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; Endotoxins; Escherichia coli Infections; Female; Inflammation; Interleukin-6; Leukocyte Count; Male; Multiple Organ Failure; Sepsis; Swine; Tobramycin; Tumor Necrosis Factor-alpha | 2018 |
Mode of bacterial killing affects the inflammatory response and associated organ dysfunctions in a porcine E. coli intensive care sepsis model.
Topics: Animals; Cefuroxime; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Inflammation; Interleukin-10; Interleukin-6; Multiple Organ Failure; Organ Dysfunction Scores; Penicillin-Binding Proteins; Prospective Studies; Sepsis; Swine; Tobramycin; Tumor Necrosis Factor-alpha | 2020 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |